1. Study identification
EU PAS Register NumberEUPAS14060
Official titleEstimating prevalence and incidence of acute myocardial infarction in a set of heterogeneous sources of observational health data collaborating in the EMIF Platform
Study title acronym
Study typeObservational study
Brief description of the studyThe European Medical Information Framework (EMIF) project has the main objective of building an infrastructure for the efficient re-use of existing health care data for epidemiological research. Within the project, the EMIF-Platform represents a federation of heterogeneous sources of health data (e.g. administrative, hospital or primary care databases, disease registries, biobanks). One of the major challenges for the EMIF project is to deal with the different characteristics of the participating data sources in order to facilitate the execution of large multi-national, multi-data source observational studies and generate high quality evidence. For this purpose, a template data derivation procedure was specifically developed. In this proof-of-concept study, the standard procedure will be applied for the identification of patients with acute myocardial infarction (AMI) in a set of heterogeneous sources of observational health data. Validity indices (sensitivity, PPV) of the data source-tailored case-finding algorithms will be estimated from available evidence, and adjusted prevalence and incidence of AMI will be estimated from the participating data sources.
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)?
Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicable
2. Research centres and Investigator details
Coordinating study entity
Centre to which the investigator belongsARS
Department/Research groupOsservatorio di Epidemiologia
Organisation/affiliationAgenzia regionale di sanità della Toscana (ARS)
Details of (Primary) lead investigator
Title Dr
Last name Giuseppe
First name Roberto
Is this study being carried out with the collaboration of a research network?
Yes
European Medical Information Framework (EMIF)
Other centres where this study is being conducted
Multiple centres
In total how many centres are involved in this Study?9
IMIM-Hospital del Mar Medical Research Institute and Universitat Pompeu Fabra, Barcelona, Spain
The Health Improvement Network, Cegedim Strategic Data Medical Research Ltd, London, United Kingdom
Quretec, Software Technology and Applications Competence Center, University of Tartu, Tartu, Estonia
Department of Clinical Epidemiology, Aarhus University Hosptial, Aarhus, Denmark
Countries in which this study is being conducted
International study
Denmark
Estonia
Italy
Netherlands
Spain
United Kingdom
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed01/01/201301/01/2013
Start date of data collection21/11/201601/02/2017
Start date of data analysis
Date of interim report, if expected
Date of final study report31/07/2019
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government body
Research councils
EU funding scheme
OtherEU/EFPIA100
5. Contact details for enquiries
Scientific Enquiries
Title Dr
Last name Giuseppe
First name Roberto
Address line 1Via Pietro Dazzi 1
Address line 250141
Address line 3
CityFlorence
Postcode50141
CountryItaly
Phone number (incl. country code)39-0554624320
Alternative phone number
Fax number (incl. country code)
Public Enquiries
Title Dr
Last name Giuseppe
First name Roberto
Address line 1Via Pietro Dazzi 1
Address line 250141
Address line 3
CityFlorence
Postcode50141
CountryItaly
Phone number (incl. country code)39-0554624320
Alternative phone number
Fax number (incl. country code)
6. Study drug(s) information
Not applicable (disease/epidemiology study)
7. Medical conditions to be studied
Medical condition(s)Yes
Acute myocardial infarction
8. Population under study
Age
Adults (45 - 64 years)
Adults (65 - 74 years)
Adults (75 years and over)
Sex
Male
Female
9. Number of subjects
Estimated total number of subjects1000000
10. Source of data
Is this study being carried out with an established data source?Yes
Data sources registered with ENCePP
Data sources not registered with ENCePP
IMASIS, Spain
EGCUT, Estonia
Sources of data
Administrative database, e.g. claims database
Routine primary care electronic patient registry
Pharmacy dispensing records
- Biobank collecting clinical information from donors of biological samples
- Hospital data source collecing information from inpatient care
11. Scope of the study
What is the scope of the study?
Disease epidemiology
to test a data derivation procedure designed to identify any event of interest from data sources with heterogeneous characteristics
Primary scope : to test a data derivation procedure designed to identify any event of interest from data sources with heterogeneous characteristics
12. Main objective(s)
What is the main objective of the study?
Estimating prevalence and incidence of acute myocardial infarction in a set
heterogeneous sources of observational health data collaborating in the
EMIF Platform in order to test a standard data derivation procedure designed to facilitate the execution of multi-national, multi-data source studies
Are there primary outcomes?No
Are there secondary outcomes?No
13. Study design
What is the design of the study?
Cohort study
14. Follow-up of patients
Will patients be followed up?Not applicable/no follow-up
15. Data analysis plan
Please provide a brief summary of the analysis method
The study population in each participating data source will include all active subjects at 1st January 2013 (cohort entry) with at least 365 days of look-back.
Prevalence and incidence of AMI observed between 1st January and 31st December 2013 will be calculated in each participating data sources according to different case definitions.
16. ENCePP seal
Are you requesting the ENCePP seal for this study?
No
17. Full protocol
Available when the study ends
18. Study Results
Not submitted
Please list the 5 most relevant publications using data from your study
ReferenceLink to web-publication
None
19. Other relevant documents
Conflict(s) of interest of
investigator(s)Not submitted
Composition of Steering Group and
ObserversNot submitted
Other documentsNot
submitted
Signed Code of
Conduct Checklist
Not submitted
Signed Code of Conduct Declaration
Not submitted
Signed Checklist for Study
Protocols
Not submitted